SAGEMCOM/NET-FEASA
Net Feasa Limited and Sagemcom SAS announce a global deal for the deployment of the Siconia™ multi-sensors device for a wide range of connected ports and maritime IoT use cases. The next generation, LoRaWAN™-compliant Siconia™ industrial device provides a capable platform for a variety of use cases with significant commercial benefit. Some of the applications include asset, vehicle & chassis tracking, reefer container monitoring, access control and maritime safety (MARSEC).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170907006112/en/
Utilising the extremely power efficient LoRaWAN™ based wireless solution, the Siconia™ device has enabled Net Feasa to deploy cost effective solutions at a price that is very attractive to both Ports and Shipping companies. Net Feasa is presently deploying these solutions in both Europe and the US.
Net Feasa COO, Nikola Nestorov, said: “We have assessed and tested a large number of Smart Port & Smart Vessel use cases using a variety of sensor devices and the Siconia™ device meets our needs for the strategic objective of taking a global lead in Smart Port and Smart Ship based IoT solutions.”
“This tight collaboration reinforces Sagemcom’s vision and strategy of the LPWAN IoT, enabling fast, flexible and cost efficient deployments on many different industrial market verticals. Our prioritized efforts in supporting asset management and logistics have found a direct and fruitful outcome within the connected port strategy of Net Feasa.” says Eric Rieul, CEO of Sagemcom Energy & Telecom.
Sagemcom, is an innovative and well-recognized international leader in the industrial Smart City, and Smart Nation market, thanks to its combination of Smart Metering, Smart Infrastructure solutions, and its full end-to-end IoT Low Power Wide Area Network (LPWAN) products portfolio, SICONIA™, ranging from infrastructure solutions, such as Carrier-Grade Gateways enabled for Geolocation, LoRa™ Network Server (LNS), Geolocation Solver, in addition to small and cost efficient Multi-usage IoT devices.
Sagemcom’s Gateways, its Network Server and Geolocation Solver, support the biggest LoRaWAN™ Network in the world to-date, in France, with +4500 Gateways nationwide, covering 93% of French population, demonstrating leading edge reliability and scalability.
About Net Feasa
Net Feasa is an IoT Service Provider dedicated to Smart Port and Smart Ship enablement and global container, chassis and asset tracking. Net Feasa has successfully validated the efficiency of a number of maritime use cases, implemented on its services platform EvenKeel™. Net Feasa has comprehensive experience building and operating remote and on-board vessel communications systems and has designed and developed dedicated Port IoT networks for ports in both Europe and North America.
About Sagemcom
A French high-tech group of international dimensions, Sagemcom operates on the broadband (digital home, set-top boxes, Internet routers, telephony and multimedia terminals), smart city (smart meter, smart grid, smart infra, smart sites and smart services), and Internet of Things markets.
With revenue of around 1.6 billion euros, Sagemcom employs 4000 people on five continents and ships every year more than 25 million terminals. Sagemcom aims to remain a world leader in communicating terminals with high added value.
www.sagemcom.com // www.facebook.com/SagemcomOfficial // https://twitter.com/Sagemcom
View source version on businesswire.com: http://www.businesswire.com/news/home/20170907006112/en/
Contact:
Net Feasa Ltd.
An Cúilín
Dingle,
County Kerry,
Ireland.
Email:
info@netfeasa.com
or
Sagemcom
Media
Contact
Marie- Caroline SARO, +336 88 84 81 74
presse@sagemcom.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom